ClonOrgan

China
Chengdu, Sichuan, China

Company profile

ClonOrgan company profile

ClonOrgan has developed a technology to humanize pig cells that will grow into human-compatible organs. The business specializes in xenotransplantation and has a one-stop R&D platform that includes raising gene-edited pigs, preclinical testing, and breeding. It is dedicated to addressing the critical shortage of clinical organ transplantation and creating the organ factory of the future. ClonOrgas was established in 2005 in Chengdu, Sichuan.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2005-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$8.3M
Last funding
Series A / 2025-09-04
Last equity funding
Series A
Investors
7
Lead investors
4

Founders and investors

Lead investors

Betta Biopharmaceutical Industry FundDingzhou YichuangLuminous Ventures (former Lightspeed China Partners)Royal Sea Capital

Investors

Betta Biopharmaceutical Industry FundBioVentureLuminous Ventures (former Lightspeed China Partners)Qipu BiotechnologyRoyal Sea Capital